{"id":"https://openalex.org/W7224112647","doi":"https://doi.org/10.21037/tcr-2026-1864","title":"An improved scoring method for human epidermal growth factor receptor-2 immunohistochemical staining in breast cancer","display_name":"An improved scoring method for human epidermal growth factor receptor-2 immunohistochemical staining in breast cancer","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7224112647","doi":"https://doi.org/10.21037/tcr-2026-1864","pmid":"https://pubmed.ncbi.nlm.nih.gov/42997922","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13743236"},"language":"en","primary_location":{"id":"doi:10.21037/tcr-2026-1864","doi":"https://doi.org/10.21037/tcr-2026-1864","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-2026-1864","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21037/tcr-2026-1864","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057616682","display_name":"Rui Guo","orcid":"https://orcid.org/0000-0003-0671-9975","observed_orcids":["https://orcid.org/0000-0003-0671-9975"]},"institutions":[{"id":"https://openalex.org/I4210131893","display_name":"Second Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/03aq7kf18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210131893"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rui Guo","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160060851","display_name":"Yi Tian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131893","display_name":"Second Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/03aq7kf18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210131893"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi Tian","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159997232","display_name":"Qiaoling Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131893","display_name":"Second Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/03aq7kf18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210131893"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiaoling Yu","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143409206","display_name":"Hong Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131893","display_name":"Second Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/03aq7kf18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210131893"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hong Huang","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159959906","display_name":"Xiaozhong Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131893","display_name":"Second Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/03aq7kf18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210131893"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaozhong Huang","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074885042","display_name":"Jun Yang","orcid":"https://orcid.org/0000-0002-1008-0388","observed_orcids":["https://orcid.org/0000-0002-1008-0388"]},"institutions":[{"id":"https://openalex.org/I4210131893","display_name":"Second Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/03aq7kf18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210131893"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jun Yang","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074885042"],"corresponding_institution_ids":["https://openalex.org/I4210131893","https://openalex.org/I87445476"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"10","first_page":"736","last_page":"736"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.8640000224113464},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8169999718666077},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9610000252723694},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8939999938011169},{"id":"https://openalex.org/keywords/her2-low","display_name":"HER2-low","score":0.7450000047683716},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.6970000267028809},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.6069999933242798},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5680000185966492},{"id":"https://openalex.org/keywords/treatment-strategy-selection","display_name":"treatment strategy selection","score":0.4009999930858612},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.4560000002384186},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7319999933242798},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.5559999942779541},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.5270000100135803},{"id":"https://openalex.org/keywords/p16","display_name":"p16","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.9092000126838684},{"id":"https://openalex.org/C74864618","wikidata":"https://www.wikidata.org/wiki/Q2332446","display_name":"Staining","level":2,"score":0.7487000226974487},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6567000150680542},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5580000281333923},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.5522000193595886},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.4921000003814697},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.49079999327659607},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.4683000147342682},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.3643999993801117},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3626999855041504},{"id":"https://openalex.org/C125473707","wikidata":"https://www.wikidata.org/wiki/Q9914","display_name":"H&E stain","level":3,"score":0.3546999990940094},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.3441999852657318},{"id":"https://openalex.org/C98717036","wikidata":"https://www.wikidata.org/wiki/Q14872994","display_name":"Progesterone receptor","level":5,"score":0.3359000086784363},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.334199994802475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2874999940395355},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.27390000224113464},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.26649999618530273},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.26579999923706055},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25450000166893005},{"id":"https://openalex.org/C3018264335","wikidata":"https://www.wikidata.org/wiki/Q2332446","display_name":"Positive staining","level":3,"score":0.25220000743865967}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.21037/tcr-2026-1864","doi":"https://doi.org/10.21037/tcr-2026-1864","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-2026-1864","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13743236","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13743236/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13743236/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transl Cancer Res","raw_type":"Text"},{"id":"pmid:42997922","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42997922","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational cancer research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21037/tcr-2026-1864","doi":"https://doi.org/10.21037/tcr-2026-1864","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-2026-1864","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224112647.pdf","grobid_xml":"https://content.openalex.org/works/W7224112647.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409157553","https://openalex.org/W4402019215","https://openalex.org/W4293388046","https://openalex.org/W6902283432","https://openalex.org/W4399441840","https://openalex.org/W4319991751","https://openalex.org/W2319577409","https://openalex.org/W4405746804","https://openalex.org/W1705540744","https://openalex.org/W4392739240"],"abstract_inverted_index":{"Background:":[0],"Anti-human":[1],"epidermal":[2],"growth":[3],"factor":[4],"receptor-2":[5],"(HER2)":[6],"antibody-drug":[7],"conjugates":[8],"(ADCs)":[9],"have":[10],"shown":[11],"substantial":[12],"clinical":[13,382],"therapeutic":[14],"benefits":[15],"for":[16,47,206,252,360],"HER2-positive":[17,249,309],"breast":[18],"cancer":[19],"(BC).":[20],"Nevertheless,":[21],"current":[22],"HER2":[23,39,60,65,80,88,109,127,142,159,166,170,173,181,185,189,224,235,244,246,272,294,304,306,323,342,353,387],"scoring":[24,40,61,225,236,295,324,343,388],"methods":[25],"are":[26],"insufficient":[27],"in":[28,49,103,121,135,151,268,328,365],"effectively":[29],"guiding":[30],"the":[31,44,219,222,233,269,290,312,321,350,361,381],"application":[32,362],"of":[33,93,105,123,137,153,197,271,300,352,363,384],"ADCs.":[34],"We":[35],"proposed":[36],"an":[37,58],"improved":[38,59,223,234,291,322,341],"method":[41,62,226,344],"to":[42,113,203,217,232,314,334,347,374,379],"optimize":[43],"treatment":[45],"strategy":[46],"ADCs":[48,364],"BC.":[50],"Methods:":[51],"This":[52],"retrospective":[53],"cross-sectional":[54],"clinicopathologic":[55],"study":[56],"introduces":[57],"that":[63],"categorizes":[64],"immunohistochemistry":[66],"(IHC)":[67],"staining":[68,102,120,134,150,205],"into":[69],"five":[70],"levels:":[71],"0,":[72],"0+,":[73],"1+,":[74],"2+,":[75],"and":[76,140,176,188,215,227,248,259,279,292,338,355],"3+.":[77],"Specifically,":[78],"(I)":[79],"IHC":[81,89,110,128,143,160,167,174,190,204],"0":[82,161],"indicates":[83],"no":[84,284],"perceptible":[85,98,116],"staining;":[86],"(II)":[87],"0+":[90,168],"any":[91],"degree":[92],"cytoplasmic":[94],"staining,":[95],"or":[96,99,117,179,308],"barely":[97,115],"incomplete":[100,118],"membrane":[101,119,133,149],"\u226410%":[104],"tumor":[106,124,138,154],"cells;":[107,125,139],"(III)":[108],"1+":[111,175],"refers":[112],"faint,":[114],">10%":[122,136,152],"(IV)":[126],"2+":[129,177],"represents":[130],"weak-to-moderate":[131],"complete":[132,147],"(V)":[141],"3+":[144,191],"signifies":[145],"intense,":[146],"circumferential":[148],"cells.":[155],"Among":[156],"these":[157],"categories,":[158],"is":[162,326,345,370],"interpreted":[163],"as":[164,169,184,192],"HER2-negative,":[165,243],"ultra-low":[171],"expression,":[172,187],"(with":[178],"without":[180],"gene":[182],"amplification)":[183],"low":[186,307],"HER2-positive.":[193],"Meanwhile,":[194],"a":[195],"total":[196],"1,448":[198,240],"paraffin-embedded":[199],"specimens":[200],"were":[201,287],"subjected":[202],"estrogen":[207],"receptor":[208,211],"(ER),":[209],"progesterone":[210],"(PR),":[212],"HER2,":[213],"P53,":[214],"P16":[216],"detect":[218],"correlation":[220],"between":[221,274,289],"pathological":[228],"parameters.":[229],"Results:":[230],"According":[231],"system,":[237],"among":[238],"all":[239],"BC":[241,301,366],"cases,":[242],"ultra-low,":[245,305],"low,":[247],"BCs":[250,278,310],"accounted":[251],"15.19%":[253],"(220/1,448),":[254],"7.87%":[255],"(114/1,448),":[256],"58.70%":[257],"(850/1,448),":[258],"18.23%":[260],"(264/1,448),":[261],"respectively.":[262],"A":[263],"significant":[264,285],"difference":[265],"was":[266],"observed":[267],"distribution":[270],"scores":[273],"hormone":[275],"receptor-positive":[276],"(HR+)":[277],"HR-negative":[280],"(HR\u2212)":[281],"BCs.":[282],"However,":[283],"differences":[286],"found":[288],"traditional":[293],"methods.":[296],"Moreover,":[297],"84.81%":[298],"(1,228/1,448)":[299],"patients":[302],"with":[303],"had":[311],"potential":[313],"benefit":[315],"from":[316],"ADC":[317],"therapy.":[318],"Conclusions:":[319],"Although":[320],"system":[325],"still":[327],"its":[329,335],"preliminary":[330],"conceptual":[331],"phase,":[332],"due":[333],"lower":[336],"costs":[337],"practicality,":[339],"this":[340,385],"expected":[346],"considerably":[348],"simplify":[349],"evaluation":[351],"status":[354],"offer":[356],"more":[357],"precise":[358],"guidance":[359],"treatment.":[367],"Consequently,":[368],"it":[369],"becoming":[371],"increasingly":[372],"imperative":[373],"conduct":[375],"multicenter":[376],"prospective":[377],"studies":[378],"explore":[380],"significance":[383],"refined":[386],"system.":[389]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-10-29T00:00:00"}